Rallybio (RLYB) Earnings Date & Reports

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RLYB is expected to report earnings to rise 15.38% to -30 cents per share on March 18

Q4'24

Est.

$-0.30

Q3'24

Beat

by $0.09

Q2'24

Missed

by $0.30

Q1'24

Est.

$-0.47

Q4'23

Missed

by $0.03

The last earnings report on November 07 showed earnings per share of -25 cents, beating the estimate of -34 cents. With 60.64K shares outstanding, the current market capitalization sits at 27.42M.

View a ticker or compare two or three

Compare

RLYB